A 60-year-old man with moderate COPD (FEV1 60% predicted) is using a SABA and a LABA/LAMA combination inhaler. He has had 3 moderate exacerbations in the past year. His blood eosinophil count is 0.35 x 10^9/L. What is the most appropriate next step in his inhaled therapy?